Concepts (307)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 19 | 2020 | 683 | 3.070 |
Why?
|
| Actins | 5 | 2020 | 616 | 2.070 |
Why?
|
| Phosphatidylserines | 11 | 2020 | 73 | 1.980 |
Why?
|
| Antiphospholipid Syndrome | 5 | 2024 | 39 | 1.770 |
Why?
|
| Phagocytosis | 8 | 2024 | 296 | 1.580 |
Why?
|
| Antigens, Surface | 7 | 2017 | 313 | 1.340 |
Why?
|
| beta 2-Glycoprotein I | 5 | 2024 | 16 | 1.220 |
Why?
|
| Platelet Activation | 8 | 2016 | 100 | 1.170 |
Why?
|
| Cardiolipins | 4 | 2024 | 34 | 1.170 |
Why?
|
| Cell-Derived Microparticles | 6 | 2019 | 39 | 1.000 |
Why?
|
| Platelet Aggregation | 8 | 2019 | 183 | 0.990 |
Why?
|
| Cofilin 1 | 3 | 2020 | 17 | 0.990 |
Why?
|
| Antibodies, Antiphospholipid | 4 | 2024 | 26 | 0.980 |
Why?
|
| Platelet Adhesiveness | 3 | 2018 | 44 | 0.970 |
Why?
|
| Microfilament Proteins | 2 | 2018 | 496 | 0.960 |
Why?
|
| Milk Proteins | 7 | 2017 | 134 | 0.920 |
Why?
|
| Thrombosis | 10 | 2023 | 747 | 0.910 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2023 | 46 | 0.870 |
Why?
|
| Endothelium, Vascular | 5 | 2012 | 901 | 0.840 |
Why?
|
| Sulfoglycosphingolipids | 5 | 2011 | 11 | 0.760 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2023 | 183 | 0.750 |
Why?
|
| Erythrocytes | 6 | 2023 | 359 | 0.720 |
Why?
|
| Blood Coagulation | 6 | 2016 | 168 | 0.690 |
Why?
|
| Clot Retraction | 1 | 2018 | 6 | 0.640 |
Why?
|
| Focal Adhesions | 1 | 2018 | 45 | 0.630 |
Why?
|
| rho-Associated Kinases | 2 | 2017 | 82 | 0.580 |
Why?
|
| Immunoglobulin Variable Region | 3 | 2008 | 176 | 0.570 |
Why?
|
| Blood Coagulation Disorders | 4 | 2019 | 115 | 0.550 |
Why?
|
| Macrophages | 3 | 2024 | 1373 | 0.530 |
Why?
|
| Thrombin | 4 | 2013 | 93 | 0.530 |
Why?
|
| Prothrombin | 2 | 2007 | 37 | 0.520 |
Why?
|
| Granuloma, Giant Cell | 1 | 2015 | 17 | 0.520 |
Why?
|
| Thrombocytopenia | 2 | 2013 | 871 | 0.490 |
Why?
|
| Blood Preservation | 2 | 2020 | 60 | 0.480 |
Why?
|
| Autoantibodies | 5 | 2023 | 598 | 0.480 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2015 | 191 | 0.470 |
Why?
|
| Bone Marrow Diseases | 1 | 2015 | 187 | 0.470 |
Why?
|
| Annexin A5 | 4 | 2016 | 75 | 0.470 |
Why?
|
| Endothelial Cells | 2 | 2018 | 1047 | 0.470 |
Why?
|
| Neutrophils | 2 | 2010 | 876 | 0.460 |
Why?
|
| Platelet Factor 4 | 1 | 2013 | 37 | 0.440 |
Why?
|
| Dasatinib | 1 | 2017 | 881 | 0.430 |
Why?
|
| Erythrocytes, Abnormal | 3 | 2011 | 20 | 0.430 |
Why?
|
| Cytoplasmic Vesicles | 2 | 2010 | 11 | 0.430 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 388 | 0.420 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2004 | 267 | 0.420 |
Why?
|
| Platelet Transfusion | 1 | 2013 | 167 | 0.420 |
Why?
|
| Gout | 1 | 2015 | 147 | 0.420 |
Why?
|
| Mice | 23 | 2024 | 36039 | 0.400 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2013 | 172 | 0.400 |
Why?
|
| Hemostasis | 3 | 2008 | 99 | 0.390 |
Why?
|
| Macrophage Activation | 2 | 2008 | 151 | 0.380 |
Why?
|
| Heparin | 1 | 2013 | 346 | 0.380 |
Why?
|
| Erythrocyte Inclusions | 1 | 2010 | 2 | 0.370 |
Why?
|
| Collagen | 1 | 2013 | 737 | 0.360 |
Why?
|
| Antibodies | 1 | 2013 | 835 | 0.350 |
Why?
|
| Ganciclovir | 1 | 2010 | 194 | 0.350 |
Why?
|
| Mice, Knockout | 10 | 2022 | 5839 | 0.340 |
Why?
|
| Thrombocythemia, Essential | 2 | 2023 | 179 | 0.340 |
Why?
|
| Animals | 26 | 2024 | 62826 | 0.340 |
Why?
|
| Peptide Fragments | 3 | 2015 | 1328 | 0.330 |
Why?
|
| Anemia, Sickle Cell | 3 | 2011 | 369 | 0.320 |
Why?
|
| Polycythemia Vera | 2 | 2023 | 268 | 0.320 |
Why?
|
| Cellular Senescence | 1 | 2010 | 390 | 0.310 |
Why?
|
| Fluorescein-5-isothiocyanate | 3 | 2017 | 52 | 0.290 |
Why?
|
| Bacteremia | 1 | 2013 | 722 | 0.290 |
Why?
|
| Citrobacter freundii | 1 | 2006 | 3 | 0.290 |
Why?
|
| Peptide Library | 2 | 2004 | 166 | 0.280 |
Why?
|
| Leukocytes | 2 | 2006 | 424 | 0.280 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2006 | 74 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 10 | 2019 | 7224 | 0.270 |
Why?
|
| Blood Coagulation Factors | 1 | 2006 | 55 | 0.260 |
Why?
|
| Cell Membrane | 2 | 2008 | 907 | 0.250 |
Why?
|
| von Willebrand Factor | 2 | 2018 | 246 | 0.240 |
Why?
|
| Inclusion Bodies | 1 | 2005 | 91 | 0.240 |
Why?
|
| Kringles | 1 | 2004 | 7 | 0.240 |
Why?
|
| Antibody Specificity | 2 | 2004 | 356 | 0.240 |
Why?
|
| Humans | 42 | 2024 | 271062 | 0.230 |
Why?
|
| Heart Transplantation | 2 | 2010 | 904 | 0.230 |
Why?
|
| Coombs Test | 1 | 2023 | 14 | 0.230 |
Why?
|
| Plasma Cells | 1 | 2005 | 202 | 0.230 |
Why?
|
| Carrier Proteins | 1 | 2012 | 2123 | 0.220 |
Why?
|
| Hemolysis | 1 | 2023 | 127 | 0.220 |
Why?
|
| Antiviral Agents | 1 | 2010 | 1254 | 0.210 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2016 | 72 | 0.210 |
Why?
|
| Immunoglobulin A | 1 | 2023 | 274 | 0.210 |
Why?
|
| Signal Transduction | 3 | 2023 | 12221 | 0.200 |
Why?
|
| Host Cell Factor C1 | 1 | 2022 | 14 | 0.200 |
Why?
|
| Glycoproteins | 2 | 2003 | 796 | 0.200 |
Why?
|
| Homocystinuria | 1 | 2022 | 21 | 0.200 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2017 | 358 | 0.200 |
Why?
|
| Phospholipids | 1 | 2002 | 171 | 0.200 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2022 | 53 | 0.190 |
Why?
|
| Altitude | 1 | 2021 | 38 | 0.190 |
Why?
|
| Mitochondria | 5 | 2019 | 1318 | 0.190 |
Why?
|
| Nitrophenols | 2 | 2020 | 95 | 0.190 |
Why?
|
| Oxidoreductases | 1 | 2022 | 168 | 0.190 |
Why?
|
| Ribosomes | 1 | 2022 | 170 | 0.190 |
Why?
|
| Sepsis | 1 | 2006 | 688 | 0.190 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2022 | 102 | 0.190 |
Why?
|
| Protein Binding | 6 | 2015 | 3536 | 0.180 |
Why?
|
| Brain Injuries | 2 | 2018 | 799 | 0.180 |
Why?
|
| Biphenyl Compounds | 2 | 2020 | 192 | 0.180 |
Why?
|
| Erythropoietin | 1 | 2021 | 218 | 0.170 |
Why?
|
| Aryldialkylphosphatase | 1 | 2019 | 11 | 0.170 |
Why?
|
| Fibrinolytic Agents | 1 | 2002 | 302 | 0.170 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 1143 | 0.170 |
Why?
|
| Boron Compounds | 2 | 2010 | 69 | 0.160 |
Why?
|
| Membrane Proteins | 2 | 2008 | 2959 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2013 | 1538 | 0.160 |
Why?
|
| Apoptosis | 6 | 2020 | 7862 | 0.160 |
Why?
|
| Cytoskeleton | 1 | 2020 | 305 | 0.160 |
Why?
|
| Cells, Cultured | 4 | 2015 | 5783 | 0.160 |
Why?
|
| Protein Interaction Maps | 1 | 2018 | 150 | 0.150 |
Why?
|
| Microvessels | 1 | 2018 | 141 | 0.140 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 1522 | 0.140 |
Why?
|
| Talin | 1 | 2016 | 15 | 0.140 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2017 | 86 | 0.140 |
Why?
|
| Permeability | 1 | 2017 | 162 | 0.140 |
Why?
|
| Capillary Permeability | 1 | 2017 | 117 | 0.140 |
Why?
|
| Hypercholesterolemia | 1 | 2019 | 268 | 0.140 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2019 | 351 | 0.140 |
Why?
|
| Platelet Function Tests | 3 | 2019 | 41 | 0.130 |
Why?
|
| Cell Adhesion | 3 | 2011 | 1047 | 0.130 |
Why?
|
| Mitochondrial Membranes | 1 | 2016 | 59 | 0.130 |
Why?
|
| Gene Deletion | 2 | 2018 | 1482 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2017 | 5106 | 0.130 |
Why?
|
| Cell Line | 4 | 2015 | 5437 | 0.130 |
Why?
|
| Flow Cytometry | 4 | 2010 | 3086 | 0.130 |
Why?
|
| Catalase | 1 | 2015 | 75 | 0.130 |
Why?
|
| Uric Acid | 1 | 2015 | 121 | 0.120 |
Why?
|
| P-Selectin | 2 | 2005 | 110 | 0.120 |
Why?
|
| Immunoglobulin Fragments | 2 | 2004 | 27 | 0.120 |
Why?
|
| Endotoxemia | 1 | 2015 | 72 | 0.120 |
Why?
|
| Lipopolysaccharides | 2 | 2015 | 593 | 0.120 |
Why?
|
| Reactive Oxygen Species | 2 | 2019 | 1011 | 0.120 |
Why?
|
| Lim Kinases | 1 | 2013 | 17 | 0.120 |
Why?
|
| Cyclooxygenase 2 | 1 | 2016 | 496 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 1153 | 0.120 |
Why?
|
| Repressor Proteins | 1 | 2022 | 1730 | 0.110 |
Why?
|
| Amides | 1 | 2013 | 118 | 0.110 |
Why?
|
| Bone Marrow | 2 | 2015 | 2434 | 0.110 |
Why?
|
| Male | 14 | 2022 | 128516 | 0.110 |
Why?
|
| Multiple Myeloma | 1 | 2005 | 2321 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 402 | 0.110 |
Why?
|
| Gene Expression | 2 | 2023 | 3679 | 0.110 |
Why?
|
| Cross Reactions | 1 | 2013 | 269 | 0.100 |
Why?
|
| Piperazines | 2 | 2020 | 2154 | 0.100 |
Why?
|
| Hypoxia | 1 | 2015 | 468 | 0.100 |
Why?
|
| Sulfonamides | 2 | 2020 | 1920 | 0.100 |
Why?
|
| Epitopes | 2 | 2004 | 711 | 0.100 |
Why?
|
| Erythrocyte Membrane | 1 | 2011 | 40 | 0.100 |
Why?
|
| Specimen Handling | 1 | 2013 | 311 | 0.090 |
Why?
|
| Protein Subunits | 2 | 2022 | 282 | 0.090 |
Why?
|
| Atherosclerosis | 1 | 2019 | 956 | 0.090 |
Why?
|
| Endocytosis | 1 | 2012 | 239 | 0.090 |
Why?
|
| Cyclophilins | 1 | 2010 | 29 | 0.090 |
Why?
|
| Liposomes | 2 | 2003 | 713 | 0.090 |
Why?
|
| Cytochromes c | 1 | 2010 | 117 | 0.090 |
Why?
|
| Binding Sites | 2 | 2007 | 2306 | 0.090 |
Why?
|
| Disease Models, Animal | 5 | 2022 | 7470 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2017 | 4993 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 556 | 0.080 |
Why?
|
| Maleimides | 1 | 2008 | 23 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 2012 | 584 | 0.080 |
Why?
|
| Ethylmaleimide | 1 | 2008 | 18 | 0.080 |
Why?
|
| Calcimycin | 1 | 2008 | 53 | 0.080 |
Why?
|
| Phenanthrenes | 1 | 2008 | 43 | 0.080 |
Why?
|
| Calcium Chloride | 1 | 2008 | 26 | 0.080 |
Why?
|
| Cerebroside-Sulfatase | 1 | 2008 | 8 | 0.080 |
Why?
|
| Edetic Acid | 1 | 2008 | 76 | 0.080 |
Why?
|
| Hemorheology | 1 | 2008 | 39 | 0.080 |
Why?
|
| Erythroid Cells | 1 | 2008 | 53 | 0.080 |
Why?
|
| Cattle | 2 | 2007 | 846 | 0.080 |
Why?
|
| Fluorescent Dyes | 1 | 2010 | 467 | 0.080 |
Why?
|
| Erythropoiesis | 1 | 2008 | 79 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 773 | 0.070 |
Why?
|
| Biopsy | 1 | 2015 | 3544 | 0.070 |
Why?
|
| Aztreonam | 1 | 2006 | 15 | 0.070 |
Why?
|
| Cytomegalovirus | 1 | 2010 | 493 | 0.070 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2012 | 1015 | 0.070 |
Why?
|
| Binding, Competitive | 1 | 2007 | 339 | 0.070 |
Why?
|
| Pyridines | 1 | 2013 | 1312 | 0.070 |
Why?
|
| Receptors, Androgen | 1 | 2012 | 922 | 0.070 |
Why?
|
| Spleen | 1 | 2008 | 735 | 0.070 |
Why?
|
| Cytomegalovirus Infections | 1 | 2010 | 484 | 0.070 |
Why?
|
| Fibrinogen | 1 | 2007 | 214 | 0.070 |
Why?
|
| HL-60 Cells | 1 | 2006 | 318 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 1726 | 0.060 |
Why?
|
| Mitochondrial Proteins | 1 | 2008 | 386 | 0.060 |
Why?
|
| Thromboplastin | 1 | 2005 | 33 | 0.060 |
Why?
|
| Hyalin | 1 | 2005 | 18 | 0.060 |
Why?
|
| Membrane Fusion | 1 | 2005 | 59 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2008 | 316 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 2094 | 0.060 |
Why?
|
| Membrane Microdomains | 1 | 2005 | 83 | 0.060 |
Why?
|
| Bacteriophage M13 | 1 | 2004 | 26 | 0.060 |
Why?
|
| Thromboembolism | 1 | 2005 | 153 | 0.060 |
Why?
|
| Binding Sites, Antibody | 1 | 2004 | 136 | 0.060 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2003 | 7 | 0.060 |
Why?
|
| Immunosorbent Techniques | 1 | 2003 | 56 | 0.060 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2004 | 62 | 0.060 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2004 | 112 | 0.060 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2005 | 225 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2013 | 6034 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 1444 | 0.060 |
Why?
|
| In Vitro Techniques | 2 | 2005 | 1745 | 0.060 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 343 | 0.050 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2004 | 248 | 0.050 |
Why?
|
| Endoplasmic Reticulum | 1 | 2005 | 335 | 0.050 |
Why?
|
| STAT Transcription Factors | 1 | 2023 | 80 | 0.050 |
Why?
|
| Protein Structure, Quaternary | 1 | 2002 | 136 | 0.050 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 4190 | 0.050 |
Why?
|
| Reticulocytes | 2 | 2015 | 61 | 0.050 |
Why?
|
| Sjogren's Syndrome | 1 | 2003 | 104 | 0.050 |
Why?
|
| Organelle Biogenesis | 1 | 2022 | 31 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2002 | 728 | 0.050 |
Why?
|
| Pregnancy | 1 | 2015 | 8096 | 0.050 |
Why?
|
| Autophagy | 1 | 2008 | 920 | 0.050 |
Why?
|
| Janus Kinases | 1 | 2023 | 175 | 0.050 |
Why?
|
| Vitamin B 12 | 1 | 2022 | 75 | 0.050 |
Why?
|
| Brain | 1 | 2015 | 4251 | 0.050 |
Why?
|
| Ribosomal Proteins | 1 | 2022 | 135 | 0.050 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2023 | 280 | 0.050 |
Why?
|
| Monocytes | 1 | 2005 | 787 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2004 | 4641 | 0.050 |
Why?
|
| Calcium | 1 | 2006 | 1597 | 0.040 |
Why?
|
| Anticoagulants | 2 | 2005 | 786 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2004 | 6784 | 0.040 |
Why?
|
| Heterozygote | 1 | 2002 | 1031 | 0.040 |
Why?
|
| Drug Design | 1 | 2002 | 378 | 0.040 |
Why?
|
| HIV-1 | 1 | 2004 | 641 | 0.040 |
Why?
|
| Stroke | 1 | 2008 | 1095 | 0.040 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2019 | 59 | 0.040 |
Why?
|
| Receptors, LDL | 1 | 2019 | 122 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2022 | 757 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2020 | 738 | 0.040 |
Why?
|
| Trauma Severity Indices | 1 | 2017 | 98 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 1037 | 0.040 |
Why?
|
| Survival | 1 | 2017 | 184 | 0.040 |
Why?
|
| Time Factors | 2 | 2008 | 13112 | 0.040 |
Why?
|
| Cyclooxygenase 1 | 1 | 2016 | 67 | 0.030 |
Why?
|
| Heart-Assist Devices | 1 | 2005 | 1053 | 0.030 |
Why?
|
| Homeostasis | 1 | 2021 | 960 | 0.030 |
Why?
|
| Acute Coronary Syndrome | 1 | 2019 | 256 | 0.030 |
Why?
|
| Inflammation | 1 | 2006 | 2525 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2022 | 1524 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 5992 | 0.030 |
Why?
|
| Tyrosine | 2 | 2008 | 510 | 0.030 |
Why?
|
| Polycythemia | 1 | 2015 | 64 | 0.030 |
Why?
|
| Fibrin | 1 | 2015 | 83 | 0.030 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2015 | 100 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2015 | 171 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 3174 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 409 | 0.030 |
Why?
|
| Chromones | 1 | 2012 | 121 | 0.030 |
Why?
|
| Castration | 1 | 2012 | 128 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2012 | 167 | 0.030 |
Why?
|
| Mutation | 2 | 2022 | 15861 | 0.020 |
Why?
|
| Female | 3 | 2022 | 148623 | 0.020 |
Why?
|
| Androstadienes | 1 | 2012 | 172 | 0.020 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2011 | 18 | 0.020 |
Why?
|
| Adult | 2 | 2010 | 81619 | 0.020 |
Why?
|
| HIV Infections | 1 | 2004 | 2157 | 0.020 |
Why?
|
| Sulfotransferases | 1 | 2011 | 43 | 0.020 |
Why?
|
| Single-Chain Antibodies | 1 | 2011 | 60 | 0.020 |
Why?
|
| Protein Engineering | 1 | 2011 | 99 | 0.020 |
Why?
|
| Morpholines | 1 | 2012 | 297 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2015 | 1397 | 0.020 |
Why?
|
| Membrane Glycoproteins | 2 | 2005 | 1107 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 861 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 3073 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 4507 | 0.020 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2008 | 8 | 0.020 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2008 | 95 | 0.020 |
Why?
|
| Disease Progression | 2 | 2012 | 6898 | 0.020 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2007 | 47 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 6485 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 284 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2006 | 33851 | 0.020 |
Why?
|
| Factor VIIa | 1 | 2005 | 26 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 7815 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 2004 | 62 | 0.020 |
Why?
|
| Solubility | 1 | 2005 | 251 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2008 | 4519 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 2004 | 102 | 0.010 |
Why?
|
| Leukocyte Common Antigens | 1 | 2005 | 192 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2012 | 2089 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 3419 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2004 | 173 | 0.010 |
Why?
|
| Waiting Lists | 1 | 2005 | 265 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2005 | 835 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2004 | 917 | 0.010 |
Why?
|
| Acute Disease | 1 | 2008 | 2511 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 1460 | 0.010 |
Why?
|
| Peptides | 1 | 2008 | 1529 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2015 | 2909 | 0.010 |
Why?
|
| Cell Survival | 1 | 2008 | 3085 | 0.010 |
Why?
|
| Cholesterol | 1 | 2005 | 678 | 0.010 |
Why?
|
| Middle Aged | 2 | 2005 | 90103 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2004 | 719 | 0.010 |
Why?
|
| Phenotype | 1 | 2012 | 6464 | 0.010 |
Why?
|
| Aged | 1 | 2006 | 73250 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 3861 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 14882 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 4389 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2005 | 6832 | 0.010 |
Why?
|